Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- AASK: ACE inhibitors most effective for chronic kidney disease
-
- Closer examination of diastolic HF needed in era of better detection technology
- DIAD: Favorable five-year outcome for asymptomatic patients with type 2 diabetes and no CAD history
- FDA approves everolimus-eluting stent for commercial distribution
- FDA committee examines use, safety of contrast agents
- FDA panel recommends expanding on diabetes drug testing to include CVD risk
- Guidelines offer indications for use of cardiac-based therapies
- Interval training may be best type of exercise to affect metabolic syndrome Roger S. Blumenthal, MD; George Clements; Andrew DeFilippis, MD
- Mortality from carotid stenting decreases as procedures increase nationally
-
- OPTIMIZE-HF: Continuation of beta-blocker therapy reduced risk for post-discharge mortality, rehospitalization
- Risk factors predicted mortality following EVAR, open surgical aneurysm repair
- Scientific statement on noninvasive coronary imaging released
- Statin therapy may be associated with lower risk of AF in women
- The Last Lecture a reminder to find accomplishment and peace in the moment Juan J. Rivera IV
- Knowledge of Stark laws essential for practitioners
- Solutions for health care challenges must balance quality care, access, finances
- Albert L. Waldo, MD, on collectibles, wisdom, medicine and more
-
- Low-cost generic programs help make medication co-pays more affordable Rhonda Cooper-DeHoff, PharmD